These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 23316808)
1. Citrulline: pharmacological perspectives and its role as an emerging biomarker in future. Kaore SN; Amane HS; Kaore NM Fundam Clin Pharmacol; 2013 Feb; 27(1):35-50. PubMed ID: 23316808 [TBL] [Abstract][Full Text] [Related]
2. [Plasma citrulline concentration--a reliable noninvasive marker of functional enterocyte mass]. Oliverius M; Kudla M; Baláz P; Valsamis A Cas Lek Cesk; 2010; 149(4):160-2. PubMed ID: 20518248 [TBL] [Abstract][Full Text] [Related]
3. Citrulline as a biomarker of intestinal failure due to enterocyte mass reduction. Crenn P; Messing B; Cynober L Clin Nutr; 2008 Jun; 27(3):328-39. PubMed ID: 18440672 [TBL] [Abstract][Full Text] [Related]
4. [Circulating citrulline levels: a biomarker for intestinal functionality assessment]. Crenn P; Hanachi M; Neveux N; Cynober L Ann Biol Clin (Paris); 2011; 69(5):513-21. PubMed ID: 22008130 [TBL] [Abstract][Full Text] [Related]
5. The citrulline generation test: proposal for a new enterocyte function test. Peters JH; Wierdsma NJ; Teerlink T; van Leeuwen PA; Mulder CJ; van Bodegraven AA Aliment Pharmacol Ther; 2008 Jun; 27(12):1300-10. PubMed ID: 18331613 [TBL] [Abstract][Full Text] [Related]
9. Plasma citrulline level as a biomarker for cancer therapy-induced small bowel mucosal damage. Barzał JA; Szczylik C; Rzepecki P; Jaworska M; Anuszewska E Acta Biochim Pol; 2014; 61(4):615-31. PubMed ID: 25473654 [TBL] [Abstract][Full Text] [Related]
10. Plasma citrulline concentration as a biomarker for bowel loss and adaptation in hospitalized pediatric patients requiring parenteral nutrition. Stultz JS; Tillman EM; Helms RA Nutr Clin Pract; 2011 Dec; 26(6):681-7. PubMed ID: 22205556 [TBL] [Abstract][Full Text] [Related]
11. Assessment of small bowel function in critical illness: potential role of citrulline metabolism. Peters JH; Beishuizen A; Keur MB; Dobrowolski L; Wierdsma NJ; van Bodegraven AA J Intensive Care Med; 2011; 26(2):105-10. PubMed ID: 21464064 [TBL] [Abstract][Full Text] [Related]
12. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Greiner A; Plischke H; Kellner H; Gruber R Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545 [TBL] [Abstract][Full Text] [Related]
13. Serum citrulline is a simple quantitative marker for small intestinal enterocytes mass and absorption function in short bowel patients. Jianfeng G; Weiming Z; Ning L; Fangnan L; Li T; Nan L; Jieshou L J Surg Res; 2005 Aug; 127(2):177-82. PubMed ID: 15921697 [TBL] [Abstract][Full Text] [Related]
14. Citrulline and the gut. Curis E; Crenn P; Cynober L Curr Opin Clin Nutr Metab Care; 2007 Sep; 10(5):620-6. PubMed ID: 17693747 [TBL] [Abstract][Full Text] [Related]
15. Plasma citrulline as a quantitative biomarker of HIV-associated villous atrophy in a tropical enteropathy population. Papadia C; Kelly P; Caini S; Corazza GR; Shawa T; Franzè A; Forbes A; Di Sabatino A Clin Nutr; 2010 Dec; 29(6):795-800. PubMed ID: 20646802 [TBL] [Abstract][Full Text] [Related]
16. [Cyclic citrullinated peptide antibodies (anti-CCP) together with some other parameters used for serologic diagnosis of rheumatoid arthritis]. Us D; Gülmez D; Hasçelik G Mikrobiyol Bul; 2003; 37(2-3):163-70. PubMed ID: 14593899 [TBL] [Abstract][Full Text] [Related]
17. Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not? Vannini A; Cheung K; Fusconi M; Stammen-Vogelzangs J; Drenth JP; Dall'Aglio AC; Bianchi FB; Bakker-Jonges LE; van Venrooij WJ; Pruijn GJ; Zendman AJ Ann Rheum Dis; 2007 Apr; 66(4):511-6. PubMed ID: 16984940 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic use of citrulline in cardiovascular disease. Romero MJ; Platt DH; Caldwell RB; Caldwell RW Cardiovasc Drug Rev; 2006; 24(3-4):275-90. PubMed ID: 17214603 [TBL] [Abstract][Full Text] [Related]
19. Anti-citrullinated protein/peptide antibodies (ACPA) in rheumatoid arthritis: specificity and relation with rheumatoid factor. Vander Cruyssen B; Peene I; Cantaert T; Hoffman IE; De Rycke L; Veys EM; De Keyser F Autoimmun Rev; 2005 Sep; 4(7):468-74. PubMed ID: 16137613 [TBL] [Abstract][Full Text] [Related]
20. The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide. Schellekens GA; Visser H; de Jong BA; van den Hoogen FH; Hazes JM; Breedveld FC; van Venrooij WJ Arthritis Rheum; 2000 Jan; 43(1):155-63. PubMed ID: 10643712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]